PICO Advisory Sub Committee Meeting - Applications scheduled to be considered
- 1354.1 – IVUS-guided coronary stent insertion, for patients undergoing percutaneous coronary intervention
- 1634 – Comprehensive genomic profiling of non-small cell lung cancer tumour tissue specimens using next generation sequencing assays
- 1643 – Two testing options for determining eligibility for access to Pharmaceutical Benefits Schedule (PBS) subsidised aducanumab in patients with early stage Alzheimer Disease
- 1646 – Whole genome sequencing of antimicrobial-resistant pathogens
- 1656 – Vertebral body tethering for adolescent idiopathic scoliosis
- 1657 – Rhenium-188 Brachytherapy for non melanoma skin cancer
- 1658 – Testing of tumour tissue to determine a positive homologous recombination deficiency status in a women newly diagnosed advanced (FIGO stage III-IV) high grade epithelial ovarian, fallopian tube or primary peritoneal cancer
- 1659 – Catheter-based renal denervation for uncontrolled elevated systolic blood pressure
- 1660 – Diagnostic testing for MET Exon 14 skipping alterations in non-small cell lung cancer to determine PBS eligibility for tepotinib treatment
- 1661 – Implantation of minimally invasive interspinous decompression spacers for moderate degenerative lumbar spinal stenosis